SUVRETTA CAPITAL MANAGEMENT, LLC

Q2 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2024
Date filed
8/14/2024
Form type
13F-HR
Num holdings
98
Total value ($000)
$2,722,294
Net value change ($000)
+29,657 (1.1%)
New positions
9
Sold out positions
11
Turnover %
14.8%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
INSM 114,077 207.9%
UNH 74,748 999.2%
AAPL 46,233 152.6%
Intra-Cellular Therapies, Inc. 40,878 61.6%
SYY 37,187 NEW
CTNM 36,159 NEW
ERAS 32,493 NEW
MCD 28,143 NEW
TSLA 26,697 NEW
ELV 23,142 87.6%
Top Reduces (Value $000, Stocks/ETFs)
CI -48,221 -96.8%
ARGX -47,994 -100.0%
MARINUS PHARMACEUTICALS, INC. -41,712 -90.3%
BHVN -38,462 -17.6%
EYPT -32,770 -42.1%
MCK -29,338 -96.5%
ACLX -24,980 -23.0%
VZ -24,338 -49.2%
BCYC -22,770 -100.0%
RPRX -19,127 -28.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 272,110 (10.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type